USA Passive

iShares MSCI ACWI ex U.S. ETF

The iShares MSCI ACWI ex U.S. ETF (the “Fund”) seeks to track the investment results of an index composed of large- and mid-capitalization non-U.S. equities.

$76.86

Key Metrics

TER 0.32% per year
Distribution policy Distributing
Fund size USD 11,129 M
Inception date March 26, 2008
Holdings 1,767
Fund currency USD
Fund domicile US
Provider iShares
For full official fund details, factsheets, and holdings, visit ishares.com (opens in new tab).

Compare similar ETFs

Fund Size
Dividend
Fees
Current
MSCI ACWI ex U.S. ETF ACWX
Fund Size
$11.2B
Dividend
2.5%
Fees
0.32%
Core S&P 500 ETF IVV
Fund Size
$722B
Dividend
1.1%
Fees
0.03%
Core U.S. Aggregate Bond ETF AGG
Fund Size
$141B
Dividend
4.0%
Fees
0.03%
State Street(R) SPDR(R) Portfolio S&P 500(R) ETF SPYM
Fund Size
$118B
Dividend
1.0%
Fees
0.02%
NASDAQ 100 ETF QQQM
Fund Size
$97.5B
Dividend
0.5%
Fees
0.15%
View 424 similar ETFs →

Historical Return

Last updated: Aug 01, 2026
1 Year +25.4% +2.5% Div
3 Years (avg.) +14.2% +2.5% Div
5 Years (avg.) +5.8% +2.5% Div

Risk & Analysis Metrics

Last updated: Aug 01, 2026

Volatility

16.29% 1 Year
15.28% 3 Years
16.51% 5 Years
17.26% 10 Years

Max Drawdown

-11.42% 1 Year
-14.41% 3 Years
-32.08% 5 Years
-38.97% 10 Years

Sharpe Ratio

1.06 1 Year
0.62 3 Years
0.15 5 Years
0.19 10 Years

Return Triangle (Heatmap)

Last updated: Aug 01, 2026
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
2011 -17.1% -4.1% 0.3% -1.4% -2.6% -1.6% 1.7% -0.9% 1.0% 1.6% 1.8% -0.1% 0.8% 1.0% 2.6%
2012 11.1% 10.3% 4.5% 1.4% 1.9% 5.2% 1.7% 3.5% 3.9% 3.9% 1.6% 2.4% 2.5% 4.2%
2013 9.5% 1.4% -1.6% -0.3% 4.0% 0.2% 2.5% 3.0% 3.2% 0.7% 1.7% 1.8% 3.7%
2014 -6.0% -6.7% -3.4% 2.7% -1.5% 1.4% 2.1% 2.4% -0.2% 0.9% 1.2% 3.2%
2015 -7.4% -2.0% 5.8% -0.4% 2.9% 3.6% 3.7% 0.6% 1.7% 1.9% 4.1%
2016 3.7% 13.1% 2.0% 5.7% 5.9% 5.6% 1.8% 2.9% 3.0% 5.3%
2017 23.4% 1.2% 6.4% 6.5% 6.0% 1.4% 2.8% 2.9% 5.5%
2018 -16.9% -1.2% 1.4% 2.1% -2.4% -0.3% 0.3% 3.5%
2019 17.5% 12.0% 9.3% 1.5% 3.5% 3.5% 6.8%
2020 6.7% 5.5% -3.3% 0.2% 0.9% 5.1%
2021 4.3% -7.9% -1.8% -0.6% 4.8%
2022 -18.6% -4.8% -2.1% 4.9%
2023 11.4% 7.4% 14.1%
2024 3.5% 15.5%
2025 29.0%

Distributions

*by ETF Portfolio Weight Last updated: Aug 01, 2026

Profit Margin Distribution

< 0%
2%
1y 3y N/A N/A
0 - 5%
8%
1y 3y N/A N/A
5 - 10%
17%
1y 3y N/A N/A
10 - 15%
16%
1y 3y N/A N/A
15 - 20%
17%
1y 3y N/A N/A
20 - 30%
17%
1y 3y N/A N/A
30 - 40%
8%
1y 3y N/A N/A
> 40%
15%
1y 3y N/A N/A

P/E Ratio Distribution

< 0
2%
1y 3y N/A N/A
0 - 10
10%
1y 3y N/A N/A
10 - 15
15%
1y 3y N/A N/A
15 - 20
21%
1y 3y N/A N/A
20 - 25
15%
1y 3y N/A N/A
25 - 35
22%
1y 3y N/A N/A
35 - 50
4%
1y 3y N/A N/A
> 50
11%
1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation
N/A
Undervalued
> 60%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
15 - 30%
0%
1y 3y N/A N/A
Fair (&plusmn;15%)
0%
1y 3y N/A N/A
Overvalued
15 - 30%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
> 60%
0%
1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap
0.0%
1y 3y N/A N/A
Small Cap
0.5%
1y 3y N/A N/A
Mid Cap
1.4%
1y 3y N/A N/A
Large Cap
54.5%
1y 3y N/A N/A
Mega Cap
43.6%
1y 3y N/A N/A
Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Portfolio Concentration

*by ETF Portfolio Weight Last updated: Aug 01, 2026
23.9% Top 5 Holdings
33.1% Top 10 Holdings
68.4% Top 50 Holdings
86.4% Top 100 Holdings
Top 5 Companies
TSM Taiwan Semiconductor Manufacturing
11.4%
SSNLF Samsung Electronics Co., Ltd.
4.7%
ASML ASML Holding NV
3.7%
HSBC HSBC Holdings Plc
2.1%
AZN AstraZeneca Plc
2.0%

Latest News

1 day ago • barrons.com

More Biotech M&A Is on the Way, Whether an AstraZeneca-Bristol Myers Deal Happens or Not

Even if a megamerger fails to materialize, investors stand to benefit from a wave of M&A activity in the biopharma sector.

1 day ago • 247wallst.com

Top Healthcare Analyst: A $400 Billion AstraZeneca-Bristol Myers Deal Could “Cut Costs in a Big Way”

Holz framed the logic bluntly. “If you take these two companies and you slash expenses, that would be the main thing here.

1 day ago • benzinga.com

AstraZeneca-Bristol Myers Merger Buzz Puts Patent Expiration and Deal Economics in Focus

As per a media report over the weekend, AstraZeneca Plc (NYSE:AZN) and Bristol Myers Squibb Co. (NYSE:BMY) are in potential discussions to form a p...

Average metrics of all companies in portfolio

Last updated: Aug 02, 2026
Market
Average
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $453B -
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 2.04% 2.01%
Beta Indicates the relationship between the price performance of a share and the market. 0.84 -
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 25.3 30.76
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -45.11 -
Profitable Companies 98% -
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 25.48 9.33
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 2.7 7.93
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 3.59 10.19
Market
Average
Enterprise Value to EBIT Enterprise Value divided by EBIT 11.92 18.56
Enterprise Value to Revenue Enterprise value divided by revenue 4.16 7.93
Total Debt to Enterprise Value Total debt divided by enterprise value 0.34 0.04
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 1.09 0.29
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 20.53% 21.90%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. +34.5% -116.0%
Return on Equity Equity divided by market cap. 23.50% 2.81%
Return on Assets Indicates a company's profitability in relation to its total assets. 10.02% 4.15%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 17.61% 3.82%

Sectors

Manufacturing 13.3%
Finance and Insurance 7.8%
Mining, Quarrying, and Oil and Gas Extraction 3.5%
Information 3.5%
Health Technology 2.8%
Technology 2.3%
Finance 1.7%
Transportation and Warehousing 1.1%
Consumer Non-Durables 0.9%
Utilities 0.6%
Retail Trade 0.5%
Energy 0.5%
Producer Manufacturing 0.5%
Professional, Scientific, and Technical Services 0.3%
Real Estate and Rental and Leasing 0.3%
Industrials 0.2%
Administrative and Support and Waste Management and Remediation Services 0.2%
Accommodation and Food Services 0.1%
Wholesale Trade 0.1%
Energy Minerals 0.1%
Healthcare 0.1%
Communications 0.1%
Educational Services 0.1%
Electronic Technology 0.1%
Non-Energy Minerals 0.0%
Health Care and Social Assistance 0.0%
Process Industries 0.0%
Industrial Services 0.0%
Other 59.5%

Countries

Japan 13.7%
Taiwan (Province of China) 8.6%
Canada 8.3%
United Kingdom 8.2%
Korea (the Republic of) 6.5%
China 6.1%
Switzerland 6.0%
France 5.2%
Germany 5.2%
Netherlands 4.1%
Australia 3.9%
India 3.7%
Spain 2.3%
Sweden 2.0%
Italy 1.9%
Hong Kong 1.5%
Brazil 1.3%
Singapore 1.2%
Denmark 1.0%
Saudi Arabia 0.8%
South Africa 0.8%
Israel 0.7%
Other 0.7%
Finland 0.7%
Mexico 0.6%
Ireland 0.5%
Belgium 0.5%
United States 0.4%
Norway 0.4%
Thailand 0.3%
Poland 0.3%
Malaysia 0.3%
Luxembourg 0.2%
Austria 0.2%
Kuwait 0.2%
Indonesia 0.2%
Greece 0.2%
Qatar 0.2%
United Arab Emirates 0.2%
Chile 0.2%
Turkey 0.1%
New Zealand 0.1%
Hungary 0.1%
Portugal 0.1%
Philippines 0.1%
Peru 0.1%
Cayman Islands 0.1%
Colombia 0.1%
Bermuda 0.1%
Czechia 0.0%
Egypt 0.0%
Macao 0.0%

Stock Screener

Select filters to narrow down the 241 investments below

241 companies

Limit holdings to companies in a single sector.

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap $2.1T
P/E Ratio 28.1
Dividends 0.9%
Total Investment $519.83M
Weight 4.67%

Loading details…

Market Cap $1.14T
P/E Ratio 8.9
Dividends 0.6%
Total Investment $216.61M
Weight 1.95%

Loading details…

Market Cap $627.85B
P/E Ratio 52.0
Dividends 0.5%
Total Investment $170.89M
Weight 1.54%

Loading details…

Market Cap $365.74B
P/E Ratio 17.4
Dividends 3.5%
Total Investment $95.97M
Weight 0.86%

Loading details…

Market Cap $294.4B
P/E Ratio 25.3
Dividends 1.9%
Total Investment $89.35M
Weight 0.80%

Loading details…

Market Cap $293.02B
P/E Ratio 17.7
Dividends 0.9%
Total Investment $87.52M
Weight 0.79%

Loading details…

Market Cap $348.5B
P/E Ratio 23.0
Dividends 2.8%
Total Investment $87.21M
Weight 0.78%

Loading details…

Market Cap $301.3B
P/E Ratio 23.8
Dividends 2.9%
Total Investment $85.09M
Weight 0.76%

Loading details…

Market Cap $257.09B
P/E Ratio 28.0
Dividends 3.8%
Total Investment $79.49M
Weight 0.71%

Loading details…

Loading details…

Market Cap $291.17B
P/E Ratio 19.0
Dividends 2.2%
Total Investment $76.62M
Weight 0.69%

Loading details…

Loading details…

Loading details…

Market Cap $223.78B
P/E Ratio 10.4
Dividends 3.1%
Total Investment $56.67M
Weight 0.51%

Loading details…

Market Cap $195.66B
P/E Ratio 10.9
Dividends 4.4%
Total Investment $56.03M
Weight 0.50%

Loading details…

Market Cap $202.6B
P/E Ratio 19.8
Dividends 2.6%
Total Investment $55.3M
Weight 0.50%

Loading details…

Market Cap $206.96B
P/E Ratio 11.1
Dividends 1.9%
Total Investment $54.86M
Weight 0.49%

Loading details…

Market Cap $213.96B
P/E Ratio 23.0
Dividends 1.6%
Total Investment $53.44M
Weight 0.48%

Loading details…

Market Cap $149.69B
P/E Ratio 57.1
Dividends 0.5%
Total Investment $50.09M
Weight 0.45%

Loading details…

Market Cap $69.02B
P/E Ratio 35.5
Dividends 1.2%
Total Investment $49.09M
Weight 0.44%

Loading details…